Evidence map›Paper›PMID 23189244›Full record

ArticleMicrobiologyOpen2012

Tellurite enters Escherichia coli mainly through the PitA phosphate transporter.

Alex O Elías, María José Abarca, Rebecca A Montes, Thomas G Chasteen, José M Pérez-Donoso, Claudio C Vásquez

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Characterization of Tellurite Toxicity toInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Impact of ISFrontiers in microbiology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Microbial Musings - February 2021.Microbiology (Reading, England) · 2021
    Article
  10. Review
  11. Article
  12. Reduction of Gold (III) and Tellurium (IV) byFrontiers in microbiology · 2018
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alex O ElíasLaboratorio de Microbiología Molecular, Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile Chile.
María José Abarca
Rebecca A Montes
Thomas G Chasteen
José M Pérez-Donoso
Claudio C Vásquez
Universidad de Santiago de Chile · CLSam Houston State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several transporters suspected to be involved in tellurite uptake in Escherichia coli were analyzed. Results showed that the PitA phosphate transporter was related to tellurite uptake. Escherichia coli ΔpitA was approximately four-fold more tolerant to tellurite, and cell viability remained almost unchanged during prolonged exposure to the toxicant as compared with wild type or ΔpitB cells. Notably, reduced thiols (toxicant targets) as well as superoxide dismutase, catalase, and fumarase C activities did not change when exposing the ΔpitA strain to tellurite, suggesting that tellurite-triggered oxidative damage is attenuated in the absence of PitA. After toxicant exposure, remaining extracellular tellurite was higher in E. coli ΔpitA than in control cells. Whereas inductively coupled plasma atomic emission spectrometric studies confirmed that E. coli ΔpitA accumulates ∼50% less tellurite than the other strains under study, tellurite strongly inhibited (32)P(i) uptake suggesting that the PitA transporter is one of the main responsible for tellurite uptake in this bacterium.

Indexed as

Escherichia coliphosphate transportPitAtellurite uptake

Identifiers

PMID23189244
PMCPMC3501828
OpenAlexW2068074925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.